MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Total Debt (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Total Debt came in at $49.7 million in Q4 2025, down 32.14% YoY from $73.2 million in Q4 2024, and down 32.65% on a QoQ basis from $73.8 million in Q2 2025.

Analysis

MeiraGTx Holdings (MGTX) Total Debt (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 6 years of Total Debt data on file, last reported at $49.7 million in Q4 2025.

  • Quarterly Total Debt fell 32.14% year-over-year to $49.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.7 million (down 32.14% YoY) and the FY2025 annual result came in at $49.7 million, down 32.14% from the prior year.
  • Total Debt slipped to $49.7 million in Q4 2025, from $73.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $73.8 million in Q2 2025 to a low of $208000.0 in Q1 2023.
  • A 5-year average of $48.6 million and a median of $71.7 million in 2023 frame the typical range for Total Debt.
  • Annual changes were most pronounced in 2022 — Total Debt slumped 72.51% — and 2024, when it surged 34703.37%.
  • Tracing MGTX's Total Debt over 5 years: stood at $953000.0 in 2021, then tumbled by 72.51% to $262000.0 in 2022, then jumped by 27426.34% to $72.1 million in 2023, then grew by 1.53% to $73.2 million in 2024, then plunged by 32.14% to $49.7 million in 2025.
  • The last three Total Debt figures came in at $49.7 million (Q4 2025), $73.8 million (Q2 2025), and $73.5 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.07 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.34 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 105.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.22 Mn
Dec 31, 2025 74.34 Mn
Sep 30, 2025 74.06 Mn
Jun 30, 2025 73.77 Mn
Mar 31, 2025 73.50 Mn
Dec 31, 2024 73.22 Mn
Sep 30, 2024 72.94 Mn
Jun 30, 2024 72.67 Mn
Mar 31, 2024 72.39 Mn
Dec 31, 2023 72.12 Mn
Sep 30, 2023 71.84 Mn
Jun 30, 2023 71.57 Mn
Mar 31, 2023 71.30 Mn
Dec 31, 2022 71.03 Mn
Sep 30, 2022 70.85 Mn
Jun 30, 2022 304,000.00
Mar 31, 2022 556,000.00
Dec 31, 2021 953,000.00
Dec 31, 2017 1.44 Mn